Stellar Biotechnologies Reports Fiscal Year 2018 Financial Results PR Newswire LOS ANGELES, Nov. 30, 2018 LOS ANGELES , Nov. 30, 2018 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, today reported financial results for the fiscal year ended September 30, 2018 and provided an update on its business. During fiscal year 2018, Stellar advanced a number of technical,...